Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Formoterol und Beclometason, ausgenommen Dosieraerosole mit der Wirkstärke 100µg/6µg (ATC-Code: R03AK08).

Conclusion of a non-exclusive rebate contract pursuant to Section 130a (8) SGB V for medicines with the active substance combination of Formoterol and Beclometason, excluding metered-dose inhalers with the strength 100µg/6µg (ATC Code: R03AK08) within the period from 01.09.2026 to 31.08.2028 with the possibility of concluding the contract at any time during the contract period ("open-house model").